medigraphic.com
ISSN 0185-3252 (Impreso)
Revista de la Asociación Médica del Centro Médico ABC

2018, Número 2

<< Anterior Siguiente >>

An Med Asoc Med Hosp ABC 2018; 63 (2)


Propuesta de protocolo de hemorragia masiva

Ortega GJP, Chávez RMA, Covarrubias VJA, Díaz HAE, Guzmán NRE, Espino NJS, Romero GP

Idioma: Español
Referencias bibliográficas: 50
Paginas: 111-116
Archivo PDF: 191.77 Kb.


RESUMEN

La hemorragia es una causa de muerte prevenible en el periodo perioperatorio. Además de las estrategias para controlar el origen del sangrado, la resucitación puede alterar los desenlaces de los pacientes. El Centro Médico ABC en sus dos sedes podría beneficiarse de la implementación de un protocolo multidisciplinario que identifique a los pacientes con hemorragia masiva y responda de forma estandarizada para su resucitación. Además de reducir la morbilidad y mortalidad, un protocolo puede ayudar a racionalizar el uso de hemocomponentes y a individualizar la terapia con base en la mejor evidencia disponible. De forma indispensable, proponemos incluir al protocolo en un modelo de gobernanza clínica para la mejora continua.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Meyer DE, Vincent LE, Fox EE, OʼKeeffe T, Inaba K, Bulger E et al. Every minute counts: time to delivery of initial massive transfusion cooler and its impact on mortality. J Trauma Acute Care Surg. 2017; 83 (1): 19-24.

  2. Fernández-Cubero JM, Medina-Arteaga A, Mingot-Castellano E, Muñoz-Pérez MI. Guía práctica para manejo de la hemorragia masiva. 12 Mayo 2017. p. 1-10.

  3. National Blood Authority. Critical Bleeding Massive Transfusion Patient Blood Management Guidelines: Module 1. 2015 [Internet]. 2011; 113. Available from: http://www.blood.gov.au/system/files/documents/pbm-module-1.pdf

  4. Goodnough LT, Levy JH, Murphy MF. Concepts of blood transfusion in adults. Lancet. 2013; 381 (9880): 1845-1854.

  5. Callum JL, Nascimento B, Alam A. Massive haemorrhage protocol: what’s the best protocol? ISBT Sci Ser. 2016; 11 (S1): 297-306.

  6. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma. 2009; 66 (2): 346-352.

  7. Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma. 2009; 66 (1): 41-48; discussion 48-49.

  8. Quintana M, Serrano A. Uso de hemoderivados. Transfusión masiva. Protocolos de transfusión masiva y de hemorragia masiva. Disponible en: http://eventos.aymon.es/wp-content/uploads/2012/10/5-USO-HEMODERIVADOS-QUINTANA.pdf

  9. Zunini-Fernández G, Rando-Huluk K, Martínez-Pelayo FJ, Castillo-Trevizo AL. Transfusión masiva y manejo del paciente traumatizado: enfoque fisiopatológico del tratamiento. Cir Cir. 2011; 79 (5): 473-480.

  10. Llau JV, Acosta FJ, Escolar G, Fernández-Mondéjar E, Guasch E, Marco P et al. Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document). Med Intensiva. 2015; 39 (8): 483-504.

  11. Association of Anaesthetists of Great Britain and Ireland, Thomas D, Wee M, Clyburn P, Walker I, Brohi K et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia. 2010; 65 (11): 1153-1161.

  12. Committee on Trauma of the American College of Surgeons. ACS TQIP Massive Transfusion in Trauma Guidelines. American College of Surgeons; Chicago, IL: 2015. p. 101-119.

  13. Savage SA, Sumislawski JJ, Zarzaur BL, Dutton WP, Croce MA, Fabian TC. The new metric to define large-volume hemorrhage: results of a prospective study of the critical administration threshold. J Trauma Acute Care Surg. 2015; 78 (2): 224-229; discussion 229-230.

  14. Wijaya R, Cheng HM, Chong CK. The use of massive transfusion protocol for trauma and non-trauma patients in a civilian setting: what can be done better? Singapore Med J. 2016; 57 (5): 238-241.

  15. Murphy CH, Hess JR. Massive transfusion: red blood cell to plasma and platelet unit ratios for resuscitation of massive hemorrhage. Curr Opin Hematol. 2015; 22 (6): 533-539.

  16. Date E. Guidelines for massive hemorrhage protocol. 2014. Available from: http://www.health.gov.nl.ca/health/bloodservices/pdf/nl_mhp_guidelines.pdf

  17. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013; 17 (2): R76.

  18. Johansson PI, Stensballe J, Ostrowski SR. Current management of massive hemorrhage in trauma. Scand J Trauma Resusc Emerg Med. 2012; 20: 47.

  19. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008; 65 (4): 748-754.

  20. Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Teixeira PG et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg. 2010; 210 (6): 957-965.

  21. Pacheco LD, Saade GR, Costantine MM, Clark SL, Hankins GD. An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 2016; 214 (3): 340-344.

  22. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 389 (10084): 2105-2116.

  23. Hovaguimian F, Myles PS. Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2016; 125 (1): 46-61.

  24. Manzano-Nunez R, Naranjo MP, Foianini E, Ferrada P, Rincon E, García-Perdomo HA et al. A meta-analysis of resuscitative endovascular balloon occlusion of the aorta (REBOA) or open aortic cross-clamping by resuscitative thoracotomy in non-compressible torso hemorrhage patients. World J Emerg Surg. 2017; 12: 30.

  25. Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. Br J Anaesth. 2000; 85 (3): 487-491.

  26. Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016; (8): CD007871.

  27. Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014; 89 (2): 228-232.

  28. Hagemo JS, Christiaans SC, Stanworth SJ, Brohi K, Johansson PI, Goslings JC et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care. 2015; 19: 97.

  29. Williamson LM, Devine DV. Challenges in the management of the blood supply. Lancet. 2013; 381 (9880): 1866-1875.

  30. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015; 313 (5): 471-482.

  31. Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick AW et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products —Massive transfusion consensus conference 2011: report of the panel. Crit Care. 2011; 15 (6): 242.

  32. Nascimento B, Callum J, Tien H, Rubenfeld G, Pinto R, Lin Y et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ. 2013; 185 (12): E583-E589.

  33. Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A et al. Evidence-based practice guidelines for plasma transfusion. Transfusion. 2010; 50 (6): 1227-1239.

  34. Samama CM, Djoudi R, Lecompte T, Nathan N, Schved JF; French Health Products Safety Agency (AFSSAPS) Expert Group. Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003. Minerva Anestesiol. 2006; 72 (6): 447-452.

  35. Jairath V, Shakur H, Edwards P, Ker K, Manno D, Gilmore I. Update on the halt-it trial progress: Tranexamic acid for the treatment of gastrointestinal haemorrhage –an international, randomised, double blind placebo controlled trial. Gut. 2014; 63 (Suppl 1): A120. Available from: http://haltit.lshtm.ac.uk/files/7614/7922/2619/Protocol_Summary_v1.1_26Aug16.pdf

  36. Dewan Y, Komolafe EO, Mejía-Mantilla JH, Perel P, Roberts I, Shakur H; CRASH-3 Collaborators. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012; 13: 87.

  37. Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia. 2015; 70 Suppl 1: 50-53, e18.

  38. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376 (9734): 23-32.

  39. Roberts I, Coats T, Edwards P, Gilmore I, Jairath V, Ker K et al. HALT-IT —tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Trials. 2014; 15: 450.

  40. Mackie IJ, Kitchen S, Machin SJ, Lowe GD; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on fibrinogen assays. Br J Haematol. 2003; 121 (3): 396-404.

  41. Webster SJ, Todd SJ, Wright CR. A retrospective cohort analysis of ionised calcium levels in major trauma patients who have received early blood product transfusion in the Emergency Department. Scand J Trauma Resusc Emerg Med. 2015; 23 (Suppl 2): O3.

  42. Lau P, Ong V, Tan WT, Koh PL, Hartman M. Use of activated recombinant factor vii in severe bleeding —evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. Transfus Med Hemother. 2012; 39 (2): 139-150.

  43. Min JJ, Gil NS, Lee JH, Ryu DK, Kim CS, Lee SM. Predictor of fluid responsiveness in the ‘grey zone’: augmented pulse pressure variation through a temporary increase in tidal volume. Br J Anaesth. 2017; 119 (1): 50-56.

  44. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016; 20: 100.

  45. Boet S, Bould MD, Fung L, Qosa H, Perrier L, Tavares W et al. Can J Anaesth. Transfer of learning and patient outcome in simulated crisis resource management: a systematic review. 2014; 61 (6): 571-582.

  46. Abatzis VT, Littlewood KE. Debriefing in simulation and beyond. Int Anesthesiol Clin. 2015; 53 (4): 151-162.

  47. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010; 137 (1): 209-220.

  48. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008; 64 (5): 1211-1217; discussion 1217.

  49. Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology. 2010; 113 (5): 1205-1219.

  50. Green L, Tan J, Grist C, Kaur M, MacCallum P. Aetiology and outcome of massive transfusion in two large London teaching hospitals over a 3-year period (2012-2014). Transfus Med. 2017; 27 Suppl 5: 342-347.




2020     |     www.medigraphic.com